SYNGAP1 and epilepsy: Heterozygous loss-of-function variants in SYNGAP1 cause autosomal mental retardation type 5 (MRD5; phenotype MIM 612621; gene/locus MIM 603384), and its common phenotypes include cognitive impairment, speech disorder, behavioral deficits, and epilepsy [3].